Hybrid treatment of aortic arch disease.

Autor:	Metzger PB; Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil., Rossi FH; Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil., Moreira SM; Seção Médica de Radiologia, Centro de Intervenções Endovascular, Instituto Dante Pazzanese de Cardiologia, São Paulo, SP, Brasil., Issa M; Secretaria da Saúde do Estado de São Paulo, São Paulo, SP, Brasil., Izukawa NM; Seção Médica de Cirurgia Vascular, Centro de Intervenções, Instituto Dante Pazzanese de Cardiologia, São Paulo, SP, Brasil., Dinkhuysen JJ; Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil., Spina Neto D; Hospital Salvalus, São Paulo, SP, Brasil., Kambara AM; Universidade Federal de São Paulo, São Paulo, SP, Brasil.
Jazyk:	English; Portuguese
Zdroj:	Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular [Rev Bras Cir Cardiovasc] 2014 Oct-Dec; Vol. 29 (4), pp. 527-36.
DOI:	10.5935/1678-9741.20140056
Abstrakt:	Introduction: The management of thoracic aortic disease involving the ascending aorta, aortic arch and descending thoracic aorta are technically challenging and is an area in constant development and innovation. Objective: To analyze early and midterm results of hybrid treatment of arch aortic disease. Methods: Retrospective study of procedures performed from January 2010 to December 2012. The end points were the technical success, therapeutic success, morbidity and mortality, neurologic outcomes, the rate of endoleaks and reinterventions. Results: A total of 95 patients treated for thoracic aortic diseases in this period, 18 underwent hybrid treatment and entered in this study. The average ages were 62.3 years. The male was present in 66.7%. The technical and therapeutic success was 94.5% e 83.3%. The perioperative mortality rate of 11.1%. There is any death during one-year follow- up. The reoperation rates were 16.6% due 2 cases of endoleak Ia and one case of endoleak II. There is any occlusion of anatomic or extra anatomic bypass during follow up. Conclusion: In our study, the hybrid treatment of aortic arch disease proved to be a feasible alternative of conventional surgery. The therapeutic success rates and re- interventions obtained demonstrate the necessity of thorough clinical follow-up of these patients in a long time.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu